An Exploratory Phase I Study With Sorafenib in Addition to Vinflunine in Progressive Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Sorafenib (Primary) ; Vinflunine (Primary)
- Indications Bladder cancer; Pelvic cancer; Urethral cancer; Urogenital cancer
- Focus Adverse reactions
- 31 Aug 2016 Planned End Date changed from 1 Jan 2016 to 1 Mar 2017.
- 31 Aug 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jan 2017.
- 26 Jun 2015 Planned End Date changed from 1 Sep 2014 to 1 Jan 2016 as reported by ClinicalTrials.gov record.